Global Radiopharmaceuticals in Nuclear Medical Market Report, History and Forecast 2014-2025, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID :QYR-14438212 | Published Date: 10-Jul-2019 | No. of pages: 148Description
TOC
Table of Contents
1 Radiopharmaceuticals in Nuclear Medical Market Overview
1.1 Radiopharmaceuticals in Nuclear Medical Product Overview
1.2 Radiopharmaceuticals in Nuclear Medical Market Segment by Type
1.2.1 Diagnostic Radiopharmaceuticals
1.2.2 Therapy Radiopharmaceuticals
1.2.3 Enriched Stable Isotopes
1.3 Global Radiopharmaceuticals in Nuclear Medical Market Size by Type
1.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales and Growth by Type
1.3.2 Global Radiopharmaceuticals in Nuclear Medical Sales and Market Share by Type (2014-2019)
1.3.3 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Type (2014-2019)
1.3.4 Global Radiopharmaceuticals in Nuclear Medical Price by Type (2014-2019)
2 Global Radiopharmaceuticals in Nuclear Medical Market Competition by Company
2.1 Global Radiopharmaceuticals in Nuclear Medical Sales and Market Share by Company (2014-2019)
2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Share by Company (2014-2019)
2.3 Global Radiopharmaceuticals in Nuclear Medical Price by Company (2014-2019)
2.4 Global Top Players Radiopharmaceuticals in Nuclear Medical Manufacturing Base Distribution, Sales Area, Product Types
2.5 Radiopharmaceuticals in Nuclear Medical Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals in Nuclear Medical Market Concentration Rate
2.5.2 Global Radiopharmaceuticals in Nuclear Medical Market Share of Top 5 and Top 10 Players
2.5.3 Mergers & Acquisitions, Expansion
3 Radiopharmaceuticals in Nuclear Medical Company Profiles and Sales Data
3.1 Bracco Imaging
3.1.1 Company Basic Information, Manufacturing Base and Competitors
3.1.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.1.3 Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.1.4 Main Business Overview
3.2 Cambridge Isotope Laboratories
3.2.1 Company Basic Information, Manufacturing Base and Competitors
3.2.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.2.3 Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.2.4 Main Business Overview
3.3 Cardinal Health
3.3.1 Company Basic Information, Manufacturing Base and Competitors
3.3.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.3.3 Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.3.4 Main Business Overview
3.4 Covidien
3.4.1 Company Basic Information, Manufacturing Base and Competitors
3.4.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.4.3 Covidien Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.4.4 Main Business Overview
3.5 Eczacibasi-Monrol
3.5.1 Company Basic Information, Manufacturing Base and Competitors
3.5.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.5.4 Main Business Overview
3.6 Fujifilm Holdings Corporation
3.6.1 Company Basic Information, Manufacturing Base and Competitors
3.6.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.6.4 Main Business Overview
3.7 GE Healthcare (Subsidiary Of General Electric Company)
3.7.1 Company Basic Information, Manufacturing Base and Competitors
3.7.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.7.4 Main Business Overview
3.8 IBA Group
3.8.1 Company Basic Information, Manufacturing Base and Competitors
3.8.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.8.3 IBA Group Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.8.4 Main Business Overview
3.9 Lantheus Medical Imaging
3.9.1 Company Basic Information, Manufacturing Base and Competitors
3.9.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.9.3 Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.9.4 Main Business Overview
3.10 Nordion
3.10.1 Company Basic Information, Manufacturing Base and Competitors
3.10.2 Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
3.10.3 Nordion Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin(2014-2019)
3.10.4 Main Business Overview
3.11 Ntp Radioisotopes
3.12 Siemens Healthcare
3.13 Taiyo Nippon Sanso Corporation
3.14 Urenco Limited
3.15 Rotem Industries
4 Radiopharmaceuticals in Nuclear Medical Market Status and Outlook by Regions
4.1 Global Market Status and Outlook by Regions
4.1.1 Global Radiopharmaceuticals in Nuclear Medical Market Size and CAGR by Regions
4.1.2 North America
4.1.3 Asia-Pacific
4.1.4 Europe
4.1.5 South America
4.1.6 Middle East and Africa
4.2 Global Radiopharmaceuticals in Nuclear Medical Sales and Revenue by Regions
4.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales and Market Share by Regions (2014-2019)
4.2.2 Global Radiopharmaceuticals in Nuclear Medical Revenue and Market Share by Regions (2014-2019)
4.2.3 Global Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin (2014-2019)
4.3 North America Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin
4.3.1 United States
4.3.2 Canada
4.3.3 Mexico
4.4 Europe Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin
4.4.1 Germany
4.4.2 UK
4.4.3 France
4.4.4 Italy
4.4.5 Russia
4.4.6 Turkey
4.5 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin
4.5.1 China
4.5.2 Japan
4.5.3 Korea
4.5.4 Southeast Asia
4.5.4.1 Indonesia
4.5.4.2 Thailand
4.5.4.3 Malaysia
4.5.4.4 Philippines
4.5.4.5 Vietnam
4.5.5 India
4.5.6 Australia
4.6 South America Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin
4.6.1 Brazil
4.7 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales, Revenue, Price and Gross Margin
4.7.1 Egypt
4.7.2 GCC Countries
5 Radiopharmaceuticals in Nuclear Medical Application/End Users
5.1 Radiopharmaceuticals in Nuclear Medical Segment by Application
5.1.1 Diagnostic Application
5.1.2 Therapeutic Application
5.1.3 Research
5.1.4 Pharmaceutical
5.1.5 Industrial
5.2 Global Radiopharmaceuticals in Nuclear Medical Product Segment by Application
5.2.1 Global Radiopharmaceuticals in Nuclear Medical Sales by Application
5.2.2 Global Radiopharmaceuticals in Nuclear Medical Sales and Market Share by Application (2014-2019)
6 Global Radiopharmaceuticals in Nuclear Medical Market Forecast
6.1 Global Radiopharmaceuticals in Nuclear Medical Sales, Revenue Forecast (2019-2025)
6.1.1 Global Radiopharmaceuticals in Nuclear Medical Sales and Growth Rate Forecast (2019-2025)
6.1.1 Global Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate Forecast (2019-2025)
6.2 Global Radiopharmaceuticals in Nuclear Medical Forecast by Regions
6.2.1 North America Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast (2019-2025)
6.2.2 Europe Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast (2019-2025)
6.2.3 Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast (2019-2025)
6.2.3.1 China
6.2.3.2 Japan
6.2.3.3 Korea
6.2.3.4 Southeast Asia
6.2.3.5 India
6.2.3.6 Australia
6.2.4 South America Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast (2019-2025)
6.2.5 Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast (2019-2025)
6.2.5.1 Egypt
6.2.5.2 GCC Countries
6.3 Radiopharmaceuticals in Nuclear Medical Forecast by Type
6.3.1 Global Radiopharmaceuticals in Nuclear Medical Sales and Revenue Forecast by Type (2019-2025)
6.3.2 Diagnostic Radiopharmaceuticals Gowth Forecast
6.3.3 Therapy Radiopharmaceuticals Gowth Forecast
6.4 Radiopharmaceuticals in Nuclear Medical Forecast by Application
6.4.1 Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2019-2025)
6.4.2 Global Radiopharmaceuticals in Nuclear Medical Forecast in Diagnostic Application
6.4.3 Global Radiopharmaceuticals in Nuclear Medical Forecast in Therapeutic Application
7 Radiopharmaceuticals in Nuclear Medical Upstream Raw Materials
7.1 Radiopharmaceuticals in Nuclear Medical Key Raw Materials
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price
7.1.3 Raw Materials Key Suppliers
7.2 Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
8 Marketing Strategy Analysis, Distributors
8.1 Marketing Channel
8.1.1 Direct Marketing
8.1.2 Indirect Marketing
8.1.3 Marketing Channel Development Trend
8.2 Distributors
8.3 Downstream Customers
9 Research Findings and Conclusion
Appendix
Methodology/Research Approach
Research Programs/Design
Market Size Estimation
Market Breakdown and Data Triangulation
Data Source
Secondary Sources
Primary Sources
Disclaimer
Tables & Figures
List of Tables and Figures
Figure Radiopharmaceuticals in Nuclear Medical Product Picture
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Status and Outlook (2014-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Status and Outlook (2014-2025)
Figure Product Picture of Diagnostic Radiopharmaceuticals
Table Major Players of Diagnostic Radiopharmaceuticals
Figure Global Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate (%)(2014-2018)
Figure Product Picture of Therapy Radiopharmaceuticals
Table Major Players of Therapy Radiopharmaceuticals
Figure Global Therapy Radiopharmaceuticals Sales (K Units) and Growth Rate (%)(2014-2019)
Figure Product Picture of Enriched Stable Isotopes
Table Major Players of Enriched Stable Isotopes
Figure Global Enriched Stable Isotopes Sales (K Units) and Growth Rate (%)(2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Comparison by Type
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share (%) by Type (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Type (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Type in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Share (%) by Type (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Share (%) by Type (2014-2019)
Figure 2018 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share (%) by Type
Table Global Radiopharmaceuticals in Nuclear Medical Price (USD/Unit) by Type (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Company (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share (%) by Company (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Share (%) by Company in 2018
Table Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) by Company (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Share (%) by Company (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Share (%) by Company in 2018
Table Global Market Radiopharmaceuticals in Nuclear Medical Average Price (USD/Unit) by Company (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Top Players Manufacturing Base Distribution and Sales Area
Table Global Radiopharmaceuticals in Nuclear Medical Top Players Product Category
Figure Global Radiopharmaceuticals in Nuclear Medical Market Share (%) of Top 5 Players
Figure Global Radiopharmaceuticals in Nuclear Medical Market Share (%) of Top 10 Players
Table Bracco Imaging Basic Information List
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Bracco Imaging Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Cambridge Isotope Laboratories Basic Information List
Figure Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Cambridge Isotope Laboratories Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Cardinal Health Basic Information List
Figure Cardinal Health Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Cardinal Health Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Covidien Basic Information List
Figure Covidien Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Covidien Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Covidien Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Covidien Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Eczacibasi-Monrol Basic Information List
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Fujifilm Holdings Corporation Basic Information List
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table GE Healthcare (Subsidiary Of General Electric Company) Basic Information List
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table IBA Group Basic Information List
Figure IBA Group Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table IBA Group Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure IBA Group Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure IBA Group Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Lantheus Medical Imaging Basic Information List
Figure Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Lantheus Medical Imaging Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Nordion Basic Information List
Figure Nordion Radiopharmaceuticals in Nuclear Medical Product Category, Application and Specification
Table Nordion Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Nordion Radiopharmaceuticals in Nuclear Medical Sales Growth Rate (2014-2019)
Figure Nordion Radiopharmaceuticals in Nuclear Medical Sales Global Market Share (%)(2014-2019)
Table Ntp Radioisotopes Basic Information List
Table Siemens Healthcare Basic Information List
Table Taiyo Nippon Sanso Corporation Basic Information List
Table Urenco Limited Basic Information List
Table Rotem Industries Basic Information List
Table Global Radiopharmaceuticals in Nuclear Medical Market Size Comparison by Regions (2014-2025)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure South America Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%)(2014-2025)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%)(2014-2025)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Regions (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Regions (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Regions (2014-2019)
Figure 2018 Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) by Regions (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share (%) by Regions (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share (%) by Regions (2014-2019)
Figure 2018 Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share (%) by Regions
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate
Table North America Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure United States Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure United States Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Canada Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Canada Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Mexico Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales Growth Rate
Table Europe Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Germany Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Germany Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) (2014-2019)
Figure UK Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure UK Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure France Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure France Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Italy Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Italy Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Russia Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Russia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Turkey Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales Growth Rate
Table Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure China Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Japan Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Korea Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Korea Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Indonesia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Thailand Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Malaysia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Philippines Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Vietnam Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure India Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Australia Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Australia Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure South America Radiopharmaceuticals in Nuclear Medical Sales Growth Rate
Table South America Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure Brazil Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure Brazil Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales Growth Rate
Table Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (%)(2014-2019)
Figure North Africa Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure North Africa Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Sales (K Units)(2014-2019)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Revenue (Million USD)(2014-2019)
Figure Diagnostic Application Examples
Figure Therapeutic Application Examples
Figure Research Examples
Figure Pharmaceutical Examples
Figure Industrial Examples
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Comparison by Application (2014-2025)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) by Application (2014-2019)
Table Global Radiopharmaceuticals in Nuclear Medical Sales Share (%) by Application (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Application (2014-2019)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) by Application in 2018
Figure Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) and Growth Rate (%) Forecast (2019-2025)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Forecast by Regions (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) Forecast by Regions (2019-2025)
Figure North America Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North America Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Europe Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Europe Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Asia-Pacific Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure China Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure China Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Japan Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Japan Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Korea Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Korea Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure India Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure India Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Australia Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Australia Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure South America Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure South America Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure Middle East and Africa Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure North Africa Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Sales (K Units) and Growth Rate (%) Forecast (2019-2025)
Figure GCC Countries Radiopharmaceuticals in Nuclear Medical Revenue and Growth Rate (%) Forecast (2019-2025)
Table Global Radiopharmaceuticals in Nuclear Medical Sales (Million USD) Forecast by Type (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Market Share (%) Forecast by Type (2019-2025)
Table Global Radiopharmaceuticals in Nuclear Medical Revenue (Million USD) Forecast by Type (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Revenue Market Share (%) Forecast by Type (2019-2025)
Figure Diagnostic Radiopharmaceuticals Sales Growth Forecast
Figure Therapy Radiopharmaceuticals Sales Growth Forecast
Table Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Forecast by Application (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales Forecast by Application (2019-2025)
Figure Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Forecast in Diagnostic Application
Figure Global Radiopharmaceuticals in Nuclear Medical Sales (K Units) Forecast in Therapeutic Application
Table Key Raw Materials Lists
Figure Key Raw Materials Price
Table Raw Materials Key Suppliers Lists
Figure Radiopharmaceuticals in Nuclear Medical Manufacturing Cost Structure
Figure Radiopharmaceuticals in Nuclear Medical Industrial Chain Analysis
Table Distributors List
Table Radiopharmaceuticals in Nuclear Medical Downstream Customers
Companies
Bracco Imaging
Cambridge Isotope Laboratories
Cardinal Health
Covidien
Eczacibasi-Monrol
Fujifilm Holdings Corporation
GE Healthcare (Subsidiary Of General Electric Company)
IBA Group
Lantheus Medical Imaging
Nordion
Ntp Radioisotopes
Siemens Healthcare
Taiyo Nippon Sanso Corporation
Urenco Limited
Rotem Industries
- PRICE
-
$3350$6700$5025Buy Now